Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04046952 · ClinicalTrials.gov registry record · NA
Comparing TR Band to Statseal in Conjunction With TR Band II
A NA study, sponsored by VA Long Beach Healthcare System.
- Terminated
- Registry status
- NA
- Development phase
- 443
- Enrollment target
NCT04046952: Clinical Trial NA study, sponsored by VA Long Beach Healthcare System.
NCT04046952 is a NA study that was terminated before completion, run by VA Long Beach Healthcare System. The registered enrollment target is 443 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04046952, a NA study, was terminated before completion, sponsored by VA Long Beach Healthcare System.
- TERMINATED
- Registry status
- NA
- Development phase
- 443 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to compare how well two different devices for achieving hemostasis perform in patients undergoing transradial procedures. Both devices are approved by the FDA for this use, and have already been used by clinicians on patients undergoing transradial procedures. It is believed that the use of both devices in combination compared to the hemostasis band (TR band) alone will shorten the time that it takes to 'seal' the artery, resulting in a shorter period of time that you would need to wear the hemostasis band.
Primary Outcome
Time to deflation for removal of the TR Band (or TR Band and Statseal) for each group was measured in minutes.
Interventions
- DEVICE Statseal with TR Band
- DEVICE TR band only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 443 participants |
| Start Date | 2019-10-10 |
| Est. Completion | 2020-12-15 |
| Phase | NA |
Why NCT04046952 stopped before completion
NCT04046952 is an interventional study that assigns participants to a tested intervention. The registered 443 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 2 interventions - of which Statseal with TR Band is the first listed.
NCT04046952 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04046952 about?
NCT04046952 is a clinical study titled "Comparing TR Band to Statseal in Conjunction With TR Band II". The purpose of this clinical study is to compare how well two different devices for achieving hemostasis perform in patients undergoing transradial procedures. Both devices are approved by the FDA for this use, and have already been used by clinicians on patients undergoing transradial procedures. I...
What is the current status of trial NCT04046952?
This trial is currently terminated. It is a NA study. The enrollment target is 443 participants. The study started on 2019-10-10. Estimated completion is 2020-12-15.
What interventions are being tested in trial NCT04046952?
The interventions under investigation include: Statseal with TR Band (DEVICE), TR band only (DEVICE).
Who is sponsoring clinical trial NCT04046952?
This trial is sponsored by VA Long Beach Healthcare System, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04046952's enrollment target sits among peer trials
443 233rd of 2000 higher than 1,768 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06780670 · 443 participants · Phase 2
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- NCT06348394 · 444 participants · NA
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion
- NCT06700343 · 444 participants · Phase 3
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
- NCT03704766 · 442 participants · NA
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI